Dr. Douglas Devries and Dr. Scott Schachter join us for an engaging discussion on neurotrophic keratitis (NK), and how it can be identified. Clinical data and information will be presented on OxervateTM (cenegermin-bkbj) — a treatment that targets the underlying pathogenesis of NK.
Sponsored by:  Dompé
Sponsored by:  Dompé
Date & Time
Monday October 19th, 2020 11:00am CDT
End Date & Time
Monday October 19th, 2020 12:00pm CDT
Session Comments And Questions